title: VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.
abstract: Thickening of the arterial intima and smooth muscle cell (SMC) proliferation remain major problems after vascular surgery and other types of vascular manipulations. We studied the effect of endothelial cell (EC)-specific vascular endothelial growth factor (VEGF) gene transfer on the thickening of the intima using a silicone collar inserted around carotid arteries that acted both as the agent that caused intimal SMC growth and as a reservoir for the transfected gene. The model preserved EC integrity and permitted direct extravascular gene transfer without any intravascular manipulation. Compared to beta-galactosidase (lacZ)-transfected control arteries, plasmid/liposome-mediated VEGF gene transfer significantly reduced intimal thickening 1 week after the gene transfer. Administration to the experimental animals of the nitric oxide (NO) synthase inhibitor L-NAME abolished the difference in intimal thickening between VEGF and lacZ-transfected arteries. Furthermore, VEGF caused NO release from cultured human umbilical vein EC. It is concluded that extravascular VEGF gene transfer attenuates intimal growth and could be useful for the prevention of intimal thickening during vascular surgery. Our results further suggest that VEGF may reduce SMC proliferation via a mechanism that involves VEGF-induced NO production from the endothelium.
authors.affiliation: A.I. Virtanen Institute, University of Kuopio, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Laitinen
authors.forename: I
authors.initials: I
authors.lastname: Zachary
authors.forename: G
authors.initials: G
authors.lastname: Breier
authors.forename: T
authors.initials: T
authors.lastname: Pakkanen
authors.forename: T
authors.initials: T
authors.lastname: Häkkinen
authors.forename: J
authors.initials: J
authors.lastname: Luoma
authors.forename: H
authors.initials: H
authors.lastname: Abedi
authors.forename: W
authors.initials: W
authors.lastname: Risau
authors.forename: M
authors.initials: M
authors.lastname: Soma
authors.forename: M
authors.initials: M
authors.lastname: Laakso
authors.forename: J F
authors.initials: JF
authors.lastname: Martin
authors.forename: S
authors.initials: S
authors.lastname: Ylä-Herttuala
mesh_terms: D000818:Animals; D002339:Carotid Arteries / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D002478:Cells, Cultured; D016228:Endothelial Growth Factors / Q000235:genetics* / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000473:pathology; D018014:Gene Transfer Techniques; D006801:Humans; D008222:Lymphokines / Q000235:genetics* / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010766:Phosphorylation; D011817:Rabbits; D017539:Tunica Intima / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D014443:Tyrosine / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D009569:Nitric Oxide; D014443:Tyrosine; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester